TY - JOUR
T1 - Effects of chronic copper exposure during early life in rhesus monkeys
AU - Araya, Magdalena
AU - Kelleher, Shannon L.
AU - Arredondo, Miguel A.
AU - Sierralta, Walter
AU - Vial, María Teresa
AU - Uauy, Ricardo
AU - Lönnerdal, Bo
PY - 2005
Y1 - 2005
N2 - Background: Whether infants regulate copper absorption and the potential effects of excess copper in early life remain poorly defined. Objective: The objective of the study was to assess copper retention, liver copper content, and liver function in infant rhesus monkeys fed infant formula containing 6.6 mg Cu/L. Design: From birth to 5 mo of age, infant rhesus monkeys were fed formula that was supplemented with copper (0.6 mg Cu/L; n = 5) or not supplemented (n = 4). In all animals, weight and crown-rump length (by anthropometry), hemoglobin, hematocrit, plasma ceruloplasmin activity, and zinc and copper concentrations were measured monthly (birth to 6 mo) and at 8 and 12 mo. When the animals were 1,5, and 8 mo old, liver copper and metallothionein concentrations, liver histology (by light and electron microscopy), and the number of Küpffer cells were assessed, and 67Cu retention was measured. Liver function was assessed by measurement of plasma alanine aminotransferase, aspartate aminotransferase, gamma-glutamyl transferase, and alkaline phosphatase activities and protein, albumin, bilirubin, and blood urea nitrogen concentrations. Results: 67Cu retention was 19.2% and 10.9% after 1 and 5 mo of copper treatment, respectively, compared with ≈75% in controls at age 2 mo. At age 8 mo, 67Cu retention was 22.9% in copper-treated animals and 31.5% in controls. Liver histology remained normal by light microscopy, with mild ultrastructural signs of cell damage at 5 mo. Liver copper concentration was 4711, 1139, and 498 μg/g dry tissue at 1, 5, and 8 mo, respectively, in copper-treated animals and 250 μg/g at 2 mo in controls. Measurements could not be completed in all animals. Conclusions: No clinical evidence of copper toxicity was observed. Copper absorption was downregulated; increases in liver copper content at ages 1 and 5 mo did not result in histologic damage. Ultrastructural changes at age 5 mo could signal early cellular damage.
AB - Background: Whether infants regulate copper absorption and the potential effects of excess copper in early life remain poorly defined. Objective: The objective of the study was to assess copper retention, liver copper content, and liver function in infant rhesus monkeys fed infant formula containing 6.6 mg Cu/L. Design: From birth to 5 mo of age, infant rhesus monkeys were fed formula that was supplemented with copper (0.6 mg Cu/L; n = 5) or not supplemented (n = 4). In all animals, weight and crown-rump length (by anthropometry), hemoglobin, hematocrit, plasma ceruloplasmin activity, and zinc and copper concentrations were measured monthly (birth to 6 mo) and at 8 and 12 mo. When the animals were 1,5, and 8 mo old, liver copper and metallothionein concentrations, liver histology (by light and electron microscopy), and the number of Küpffer cells were assessed, and 67Cu retention was measured. Liver function was assessed by measurement of plasma alanine aminotransferase, aspartate aminotransferase, gamma-glutamyl transferase, and alkaline phosphatase activities and protein, albumin, bilirubin, and blood urea nitrogen concentrations. Results: 67Cu retention was 19.2% and 10.9% after 1 and 5 mo of copper treatment, respectively, compared with ≈75% in controls at age 2 mo. At age 8 mo, 67Cu retention was 22.9% in copper-treated animals and 31.5% in controls. Liver histology remained normal by light microscopy, with mild ultrastructural signs of cell damage at 5 mo. Liver copper concentration was 4711, 1139, and 498 μg/g dry tissue at 1, 5, and 8 mo, respectively, in copper-treated animals and 250 μg/g at 2 mo in controls. Measurements could not be completed in all animals. Conclusions: No clinical evidence of copper toxicity was observed. Copper absorption was downregulated; increases in liver copper content at ages 1 and 5 mo did not result in histologic damage. Ultrastructural changes at age 5 mo could signal early cellular damage.
UR - http://www.scopus.com/inward/record.url?scp=20544433235&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=20544433235&partnerID=8YFLogxK
U2 - 10.1093/ajcn/81.5.1065
DO - 10.1093/ajcn/81.5.1065
M3 - Article
C2 - 15883430
AN - SCOPUS:20544433235
VL - 81
SP - 1065
EP - 1071
JO - American Journal of Clinical Nutrition
JF - American Journal of Clinical Nutrition
SN - 0002-9165
IS - 5
ER -